Benjamin Wu
Impact in
- Oncology top 5%
- CAR-T cell therapy research
- Cancer Immunotherapy and Biomarkers
- Immunology top 10%
- Immunotherapy and Immune Responses
- Biosimilars and Bioanalytical Methods
Papers in ⓘ
- Oncology 36
- Cancer Immunotherapy and Biomarkers 15
- HER2/EGFR in Cancer Research 10
- Cancer Treatment and Pharmacology 7
- CAR-T cell therapy research 7
- Co-authors
- Min Zhu (5 shared papers)Sandhya Girish (5 shared papers)René Bruno (15 shared papers)Andreas Wolf (4 shared papers)Colby S. Shemesh (4 shared papers)Andrew Chow (3 shared papers)Jessica Johnson (2 shared papers)Ben‐Quan Shen (1 shared paper)
- Journals
- Journal of Clinical Oncology (10 papers)Clinical Pharmacology & Therapeutics (7 papers)Clinical and Translational Science (3 papers)CPT Pharmacometrics & Systems Pharmacology (3 papers)Cancer Chemotherapy and Pharmacology (3 papers)
- Partner nations
- United StatesFranceSwitzerland
In The Last Decade
Benjamin Wu
60 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 92
- Oncology 567
- Immunology 397
- Radiology, Nuclear Medicine and Imaging 285
- Cancer Research 145
- Hepatology 68
Countries citing papers authored by Benjamin Wu
This map shows the geographic impact of Benjamin Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Benjamin Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Benjamin Wu more than expected).
Fields of papers citing papers by Benjamin Wu
This network shows the impact of papers produced by Benjamin Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Benjamin Wu. The network helps show where Benjamin Wu may publish in the future.
Co-authors
The 25 scholars most cited alongside Benjamin Wu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 62 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 188 | |
| 2 | 2016 | 157 | |
| 3 | 2019 | 62 | |
| 4 | 2013 | 60 | |
| 5 | 2015 | 56 | |
| 6 | 2004 | 47 | |
| 7 | 2015 | 45 | |
| 8 | 2021 | 39 | |
| 9 | 2019 | 36 | |
| 10 | 2020 | 30 | |
| 11 | [Effect of acupuncture on interleukin-2 level and NK cell immunoactivity of peripheral blood of malignant tumor patients]. | 1994 | 29 |
| 12 | 2004 | 27 | |
| 13 | 2021 | 24 | |
| 14 | 2021 | 24 | |
| 15 | 2013 | 22 | |
| 16 | 2016 | 21 | |
| 17 | 2018 | 21 | |
| 18 | 2017 | 20 | |
| 19 | 2010 | 19 | |
| 20 | 2021 | 19 |
About Benjamin Wu
Benjamin Wu is a scholar working on Oncology, Nephrology, Immunology, Radiology, Nuclear Medicine and Imaging and Hepatology, having authored 62 papers that have together received 1.2k indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (17 papers), Cancer Immunotherapy and Biomarkers (15 papers), Biosimilars and Bioanalytical Methods (12 papers), HER2/EGFR in Cancer Research (10 papers), Cancer Treatment and Pharmacology (7 papers), CAR-T cell therapy research (7 papers), Angiogenesis and VEGF in Cancer (6 papers) and Hepatocellular Carcinoma Treatment and Prognosis (5 papers). The work is most often cited by research in Oncology (567 citations), Immunology (397 citations), Radiology, Nuclear Medicine and Imaging (285 citations), Cancer Research (145 citations) and Hepatology (68 citations). Benjamin Wu has collaborated with scholars based in United States, France and Switzerland. Frequent co-authors include Min Zhu, Sandhya Girish, René Bruno, Andreas Wolf, Colby S. Shemesh, Andrew Chow, Jessica Johnson, Ben‐Quan Shen, Patrick Twomey and Christian Brandl. Their work appears in journals such as Journal of Clinical Oncology, Clinical Pharmacology & Therapeutics, Clinical and Translational Science, CPT Pharmacometrics & Systems Pharmacology and Cancer Chemotherapy and Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.